Farther Finance Advisors, LLC

Position in PCVX — Vaxcyte, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in PCVX

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$23,193

-$9,232 QoQ

Shares Held

399

-28.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#263

of 329 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,699,251 across 282 Biotechnology names. PCVX ranks #77 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,922	$2,444,905
2	MRNA	Moderna, Inc.	15,429	$1,080,492
3	ARWR	Arrowhead Pharmaceuticals, Inc.	12,088	$985,292
4	HALO	Halozyme Therapeutics, Inc.	11,241	$879,833
5	EXEL	Exelixis, Inc.	14,171	$771,044
6	REGN	Regeneron Pharmaceuticals, Inc.	1,075	$670,305
7	VKTX	Viking Therapeutics, Inc.	15,171	$591,820
8	BMRN	Biomarin Pharmaceutical Inc	7,871	$450,378

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,193	399	-28.5%	Shares	Sole	2026-07-17
2026-03-31	$32,425	558	+62.7%	Shares	Sole	2026-04-07
2025-12-31	$15,826	343	+55.2%	Shares	Sole	2026-01-23
2025-09-30	$7,960	221	+62.5%	Shares	Sole	2025-10-14
2025-06-30	$4,421	136	+37.4%	Shares	Sole	2025-07-11
2025-03-31	$3,738	99	+6.5%	Shares	Sole	2025-04-14
2024-12-31	$7,612	93	+8.1%	Shares	Sole	2025-02-10
2024-09-30	$9,827	86	+11.7%	Shares	Sole	2024-10-29
2024-06-30	$5,814	77	+14.9%	Shares	Sole	2024-07-31
2024-03-31	$4,576	67	0.0%	Shares	Sole	2024-05-14
2023-12-31	$4,207	67	+857.1%	Shares	Sole	2024-02-15
2023-09-30	$356	7	+250.0%	Shares	Sole	2023-11-14
2023-06-30	$99	2	—	Shares	Sole	2024-05-14
No filing history on record for this holder in this stock.